(Q33343866)

26 July 2017

title

Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia (English)

1 reference

heparin-induced thrombocytopenia

26 July 2017

1 reference

1 reference

1 reference

Fabris F

1

1 reference

26 July 2017

Luzzatto G

2

1 reference

26 July 2017

Soini B

3

1 reference

26 July 2017

Ramon R

4

1 reference

26 July 2017

Scandellari R

5

1 reference

26 July 2017

Randi ML

6

1 reference

26 July 2017

Girolami A

7

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

Journal of Internal Medicine

26 July 2017

published in

1 reference

26 July 2017

volume

252

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

149-154

1 reference

Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

The biological basis of immune heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

Temporal aspects of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

Heparin-induced thrombocytopenia and thrombosis: clinical and laboratory studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

A 14-year study of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

Determination of heparin-platelet factor 4-IgG antibodies improves diagnosis of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2796.2002.01021.X

10.1046/J.1365-2796.2002.01021.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference